| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Auris Medical Holding Ltd (NASDAQ: EARS)
EARS Technical Analysis
1.5
| As on 24th Sep 2021 EARS SHARE Price closed @ 2.39 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.84 & Buy for SHORT-TERM with Stoploss of 1.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EARSSHARE Price
| Open | 2.37 | Change | Price | % |
| High | 2.47 | 1 Day | 0.05 | 2.14 |
| Low | 2.32 | 1 Week | 0.12 | 5.29 |
| Close | 2.39 | 1 Month | -0.72 | -23.15 |
| Volume | 144459 | 1 Year | 1.60 | 202.53 |
| 52 Week High 5.23 | 52 Week Low 0.79 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EARS Daily Charts |
EARS Intraday Charts |
Whats New @ Bazaartrend |
EARS Free Analysis |
|
|
EARS Important Levels Intraday
| RESISTANCE | 2.68 |
| RESISTANCE | 2.59 |
| RESISTANCE | 2.53 |
| RESISTANCE | 2.47 |
| SUPPORT | 2.31 |
| SUPPORT | 2.25 |
| SUPPORT | 2.19 |
| SUPPORT | 2.10 |
EARS Forecast April 2024
| 4th UP Forecast | 13.61 |
| 3rd UP Forecast | 10.01 |
| 2nd UP Forecast | 7.79 |
| 1st UP Forecast | 5.56 |
| 1st DOWN Forecast | -0.78 |
| 2nd DOWN Forecast | -3.01 |
| 3rd DOWN Forecast | -5.23 |
| 4th DOWN Forecast | -8.83 |
EARS Weekly Forecast
| 4th UP Forecast | 3.33 |
| 3rd UP Forecast | 3.03 |
| 2nd UP Forecast | 2.84 |
| 1st UP Forecast | 2.66 |
| 1st DOWN Forecast | 2.12 |
| 2nd DOWN Forecast | 1.94 |
| 3rd DOWN Forecast | 1.75 |
| 4th DOWN Forecast | 1.45 |
EARS Forecast2024
| 4th UP Forecast | 13.64 |
| 3rd UP Forecast | 10.03 |
| 2nd UP Forecast | 7.8 |
| 1st UP Forecast | 5.57 |
| 1st DOWN Forecast | -0.79 |
| 2nd DOWN Forecast | -3.02 |
| 3rd DOWN Forecast | -5.25 |
| 4th DOWN Forecast | -8.86 |
Auris Medical Holding Ltd ( NASDAQ USA Symbol : EARS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EARS Business Profile
Auris Medical Holding Ltd., a clinical-stage biopharmaceutical company, developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy, and CNS disorders. The company's Phase 3 programs under the development include Keyzilen (AM-101) for the treatment of acute inner ear tinnitus; and Sonsuvi (AM-111) for the treatment of acute inner ear hearing loss. It is also developing AM-125 that is in Phase 2 clinical trial for the intranasal treatment of acute peripheral vertigo; AM-201, which has completed Phase 1b clinical trial for the prevention of antipsychotic induced weight gain and drowsiness; and AM-301, a drug-free nasal spray for protection against airborne viruses and allergens, as well as AM-102 for the tinnitus treatment. The company has a collaboration and license agreement with INSERM; and Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders. Auris Medical Holding Ltd. was founded in 1998 and is headquartered in Hamilton, Bermuda. Address: Clarendon House, Hamilton, Bermuda, HM 11
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service